Plasma levels of malondialdehyde, a product of cyclo-oxygenase-dependent and independent lipid peroxidation in rheumatoid arthritis: a correlation with disease activity.
- Published Article
Prostaglandins and Medicine
- Publication Date
Jan 01, 1979
Plasma levels of malondialdehyde (MDA), indicating the sum of lipid peroxidation dependent and independent of cyclo-oxygenase activity, were measured in rheumatoid arthritis (RA) patients. MDA levels were increased in those patients most severely diseased. Higher levels of MDA correlated with more active RA.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/01/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/121600